Champions Oncology Competitors and Similar CompaniesClear all

Champions Oncology's competitors and similar companies include Mirati Therapeutics, Anavex, Adagene and UT Health San Antonio MD Anderson Cancer Center.

	Champions Oncology Champions Oncology is an oncology research company that provides drug development solutions for the pharmaceutical industry.	Mirati Therapeutics Mirati Therapeutics is an oncology company that designs and develops targeted therapies to address the genetic drivers of cancer.	Anavex Anavex is a biopharmaceutical company developing drugs for the treatment of cancer and neurological diseases.	Adagene Adagene is an antibody discovery and development biotechnology company specializing in oncology immunotherapy.	UT Health San Antonio MD Anderson Cancer Center UT Health San Antonio MD Anderson Cancer Center is an institution that researches cancer and provides patients care.
Founding Date	Founding Date 2007	Founding Date 2013	Founding Date 2006	Founding Date 2012	Founding Date N/A
Type	Type Public	Type Subsidiary	Type Public	Type Public	Type Subsidiary
Tags	Tags Healthcare clinical research drug development healthtech oncology therapy	Tags Healthcare biotech clinical research drug development oncology therapy	Tags Healthcare biotech clinical research drug development healthtech life sciences oncology pharma therapy	Tags Healthcare biotech clinical research drug development oncology therapy	Tags Healthcare biotech clinical research drug development oncology therapy
Locations	Locations Hackensack, US HQ Rehovot, IL Milan, IT Rockville, US	Locations San Diego, US HQ Zug, CH	Locations New York, US HQ Reno, US	Locations Suzhou, CN HQ San Diego, US San Francisco, US	Locations San Antonio, US HQ
Employees	Employees 2131% increase	Employees 666% decrease	Employees 1623% increase	Employees 13821% decrease	Employees N/A
Valuation ($)	Valuation ($) 54.1 m	Valuation ($) N/A	Valuation ($) 484.6 m	Valuation ($) 137.2 m	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) $56.9m (FY, 2025)	Revenue (est.) $12.4m (FY, 2022)	Revenue (est.) N/A	Revenue (est.) $7.7m (FY, 2025)	Revenue (est.) N/A
Cost of goods	Cost of goods $28.4m (FY, 2025)	Cost of goods $600k (FY, 2022)	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit $28.6m (FY, 2025)	Gross profit $11.8m (FY, 2022)	Gross profit N/A	Gross profit $7.7m (FY, 2025)	Gross profit N/A
Net income	Net income $4.7m (FY, 2025)	Net income ($740.9m) (FY, 2022)	Net income ($46.4m) (FY, 2025)	Net income ($17.6m) (FY, 2025)	Net income N/A
Funding
Total funding raised	Total funding raised $ 36.8m	Total funding raised N/A	Total funding raised $ 12.6m	Total funding raised $ 155m	Total funding raised N/A